These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9539099)

  • 1. Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients. II. Treatment with connecting segment-1 peptides prevents chronic rejection by attenuating arteriosclerotic development and suppressing intragraft T cell and macrophage activation.
    Korom S; Hancock WW; Coito AJ; Kupiec-Weglinski JW
    Transplantation; 1998 Mar; 65(6):854-9. PubMed ID: 9539099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression.
    Coito AJ; Korom S; Graser E; Volk HD; Van De Water L; Kupiec-Weglinski JW
    Transplantation; 1998 Mar; 65(5):699-706. PubMed ID: 9521206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients.
    Coito AJ; Onodera K; Kato H; Busuttil RW; Kupiec-Weglinski JW
    Am J Pathol; 2000 Oct; 157(4):1207-18. PubMed ID: 11021825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of alpha 4 beta 1-integrin-fibronectin adhesive interactions prevents chronic allograft rejection in sensitized recipients.
    Coito AJ; Korom S; Hancock WW; Kupiec-Weglinski JW
    Transplant Proc; 1998 Jun; 30(4):939-40. PubMed ID: 9636377
    [No Abstract]   [Full Text] [Related]  

  • 5. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
    Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
    J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
    Chandraker A; Russell ME; Glysing-Jensen T; Willett TA; Sayegh MH
    Transplantation; 1997 Apr; 63(8):1053-8. PubMed ID: 9133464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor.
    Verfaillie CM; Benis A; Iida J; McGlave PB; McCarthy JB
    Blood; 1994 Sep; 84(6):1802-11. PubMed ID: 7521691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
    Murphy B; Kim KS; Buelow R; Sayegh MH; Hancock WW
    Transplantation; 1997 Jul; 64(1):14-9. PubMed ID: 9233694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
    Shirwan H; Barwari L; Khan NS
    Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats.
    Coito AJ; Binder J; de Sousa M; Kupiec-Weglinski JW
    Transplantation; 1994 Feb; 57(4):599-605. PubMed ID: 8116048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homing of in vitro-generated donor antigen-reactive CD4+ T lymphocytes to renal allografts is alpha 4 beta 1 but not alpha L beta 2 integrin dependent.
    Hammer MH; Zhai Y; Katori M; Ritter T; Volk HD; Coito AJ; Kupiec-Weglinski JW
    J Immunol; 2001 Jan; 166(1):596-601. PubMed ID: 11123342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.
    Utans U; Arceci RJ; Yamashita Y; Russell ME
    J Clin Invest; 1995 Jun; 95(6):2954-62. PubMed ID: 7769138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel recognition site in the C-terminal heparin-binding domain of fibronectin by integrin alpha 4 beta 1 receptor on HL-60 cells.
    Mohri H; Katoh K; Iwamatsu A; Okubo T
    Exp Cell Res; 1996 Feb; 222(2):326-32. PubMed ID: 8598221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.